ArticleOncoimmunology
Trial Watch: Toll-like receptor agonists in oncological indications.
Fernando Aranda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
cites it
ArticleOncoimmunology
Fernando Aranda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.